Auckland, New Zealand

Shangjin Yang

USPTO Granted Patents = 4 


Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovative Mind of Shangjin Yang: Pioneering Cancer Therapy Solutions

Introduction: Shangjin Yang, based in Auckland, New Zealand, is a notable inventor recognized for his significant contributions to cancer treatment innovations. With four patents to his name, he is at the forefront of developing novel therapeutic approaches aimed at improving patient outcomes in oncology.

Latest Patents: Shangjin Yang's recent patents showcase his commitment to advancing cancer therapy. One of his latest innovations is titled "Tricyclic 1,2,4-triazine oxides and compositions for therapeutic use in cancer treatments." This invention involves novel tricyclic 1,2,4-triazine-1-oxides and tricyclic 1,2,4-triazine-1,4-dioxides. These compounds are designed as hypoxia-selective drugs and radiosensitizers for cancer therapy, either alone or in conjunction with radiation and other anticancer drugs.

Another significant patent by Yang is focused on "Nitroaniline-based alkylating agents and their use as prodrugs." This patent describes nitroaniline-based unsymmetrical mustards, which are proposed as prodrugs for gene-dependent enzyme prodrug therapy (GDEPT) and cell ablation therapies. These agents work alongside nitroreductase enzymes, acting as hypoxia-selective cytotoxins and potential anticancer agents.

Career Highlights: Shangjin Yang's career is marked by his work with Auckland Uniservices Limited, where he has played a crucial role in the research and development of innovative cancer treatment solutions. His dedication to his field and his research-oriented approach have made him a key figure in his company.

Collaborations: Throughout his career, Yang has collaborated with esteemed colleagues such as William Alexander Denny and William Robert Wilson. Together, they contribute to the ongoing development of cutting-edge therapies that hold promise for the future of cancer treatment.

Conclusion: Shangjin Yang exemplifies the spirit of innovation within the medical research field. His patents showcase his ability to think creatively and address challenging problems in cancer therapy. As he continues to push the boundaries of science and medicine, the impact of his work will likely resonate within the industry, providing hope for improved treatment options for patients around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…